Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -724.44M | 833.22M | -673.22M | 638.03M | |
| Total Depreciation and Amortization | -3.14M | 203.97M | -2.77M | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 1.90B | -996.17M | -245.97M | -467.94M | |
| Change in Net Operating Assets | -376.78M | 796.72M | 1.75B | 267.43M | |
| Cash from Operations | 797.53M | 837.74M | 826.74M | 437.52M | |
| Capital Expenditure | -53.55M | -112.72M | -185.72M | -145.02M | |
| Sale of Property, Plant, and Equipment | -376.60K | 1.45M | 50.94M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -886.61M | -938.12M | -187.74M | -425.11M | |
| Cash from Investing | -940.53M | -1.05B | -322.53M | -570.13M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 2.51B | 5.93B | 2.03B | -2.03B | |
| Issuance of Common Stock | 0.00 | 12.00M | 11.00M | 115.00M | |
| Repurchase of Common Stock | -3.93B | -3.00M | -1.00M | -1.00M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -3.03M | -612.93M | |
| Other Financing Activities | -4.94B | -8.32B | -4.07B | -51.00M | |
| Cash from Financing | -39.48M | -14.63M | -17.07M | -625.85M | |
| Foreign Exchange rate Adjustments | 9.59M | 32.71M | 22.92M | -7.85M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -172.89M | -193.56M | 510.06M | -766.31M | |